全文获取类型
收费全文 | 4234篇 |
免费 | 262篇 |
国内免费 | 56篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 448篇 |
妇产科学 | 475篇 |
基础医学 | 875篇 |
口腔科学 | 174篇 |
临床医学 | 241篇 |
内科学 | 542篇 |
皮肤病学 | 19篇 |
神经病学 | 136篇 |
特种医学 | 34篇 |
外科学 | 128篇 |
综合类 | 477篇 |
预防医学 | 400篇 |
眼科学 | 105篇 |
药学 | 383篇 |
1篇 | |
中国医学 | 88篇 |
肿瘤学 | 16篇 |
出版年
2024年 | 9篇 |
2023年 | 67篇 |
2022年 | 103篇 |
2021年 | 158篇 |
2020年 | 118篇 |
2019年 | 96篇 |
2018年 | 120篇 |
2017年 | 132篇 |
2016年 | 135篇 |
2015年 | 140篇 |
2014年 | 214篇 |
2013年 | 341篇 |
2012年 | 195篇 |
2011年 | 214篇 |
2010年 | 191篇 |
2009年 | 194篇 |
2008年 | 159篇 |
2007年 | 172篇 |
2006年 | 175篇 |
2005年 | 157篇 |
2004年 | 152篇 |
2003年 | 90篇 |
2002年 | 101篇 |
2001年 | 75篇 |
2000年 | 61篇 |
1999年 | 61篇 |
1998年 | 66篇 |
1997年 | 49篇 |
1996年 | 50篇 |
1995年 | 33篇 |
1994年 | 48篇 |
1993年 | 36篇 |
1992年 | 35篇 |
1991年 | 47篇 |
1990年 | 48篇 |
1989年 | 46篇 |
1988年 | 34篇 |
1987年 | 27篇 |
1986年 | 24篇 |
1985年 | 65篇 |
1984年 | 51篇 |
1983年 | 39篇 |
1982年 | 45篇 |
1981年 | 35篇 |
1980年 | 34篇 |
1979年 | 20篇 |
1978年 | 25篇 |
1977年 | 24篇 |
1976年 | 15篇 |
1975年 | 8篇 |
排序方式: 共有4552条查询结果,搜索用时 15 毫秒
1.
背景 呼吸道合胞病毒(RSV)毛细支气管炎易出现反复喘息,且下呼吸道分泌物中半胱氨酸白三烯(CysLTs)水平升高。而孟鲁司特是一种白三烯受体拮抗剂,关于其治疗RSV毛细支气管炎症状的研究相对较少。目的 探讨孟鲁司特改善婴幼儿RSV毛细支气管炎后症状及减轻反复喘息发作的有效性和安全性。方法 2015年6月-2017年6月连续纳入在潍坊市妇幼保健院出院的RSV毛细支气管炎患儿,随机分为治疗组、对照组。Ⅰ期,治疗组:口服孟鲁司特颗粒(4 mg)12周,1次/d;对照组:口服安慰剂12周,1次/d。对两组无症状天数、个人日记评分进行评估。随访9个月(Ⅱ期),观察Ⅰ+Ⅱ期反复喘息人数和医疗资源应用情况等。依据意向性分析(ITT)原则,应用全分析集(FAS)分析数据。结果 共纳入研究对象186例,治疗组92例,对照组94例。治疗组完成Ⅰ期研究的患儿为89例,对照组为90例;治疗组完成Ⅰ+Ⅱ期的患儿为84例,对照组为86例。治疗组平均依从性为97.8%(7 560/7 728),对照组平均依从性为97.4%(7 690/7 896),两组患儿平均依从性比较,差异无统计学意义(χ2=3.16,P=0.07)。在Ⅰ期研究期间,两组无症状天数、日间无症状天数、夜间无症状天数、个人日记评分比较,差异均无统计学意义(P>0.05)。在整个研究过程中(Ⅰ+Ⅱ期),治疗组RSV毛细支气管炎喘息复发人数少于对照组(P<0.05),治疗组喘息患儿出现2次及以上喘息比例低于对照组(χ2=5.14,P=0.02)。Ⅰ+Ⅱ期研究期间治疗组医疗资源应用人数、β-受体激动剂应用人数、糖皮质激素应用人数、住院人数低于对照组(P<0.05)。在事后亚组分析中,治疗组有湿疹史与父母哮喘史的患儿中无症状天数〔(49.7±20.2)、(51.3±20.9)d〕多于对照组〔(36.3±20.4)、(37.8±19.3)d〕(t=2.19,P=0.03;t=2.24,P=0.03)。整个研究过程中没有患儿因不良反应退出研究,两组间胃肠道紊乱、皮疹、转氨酶升高发生率比较,差异均无统计学意义(χ2=0.23,P=0.63;χ2=0.03,P=0.86;χ2=0.15,P=0.69)。结论 口服孟鲁司特(4 mg)12周不能改善RSV毛细支气管炎患儿呼吸道症状,但能降低患儿反复喘息发作次数。口服孟鲁司特(4 mg)有一定效果且安全。 相似文献
2.
《Vaccine》2020,38(50):7916-7927
Respiratory syncytial virus (RSV) is the major cause of acute lower respiratory illness in children of less than 5 years of age which usually results in hospitalization or even in death. Vaccine development is hampered in consequence of a failed vaccine trial with fatalities in the 1960s. Even though research has been more focused on the RSV fusion protein in its pre-fusion conformation, maternal vaccination with post-fusion protein (post F) was considered as a promising vaccine strategy for passive immunization of babies, because post F preserves very potent neutralizing epitopes. We extensively analyzed post F-binding B cell receptor (BCR) repertoires of three vaccinees who received a post F-subunit vaccine in the context of a first-in-human, Phase 1, randomized, observer-blind, placebo-controlled clinical trial (ClinicalTrials.gov Identifier: NCT02298179). In order to compare the vaccine-induced BCR repertoires with BCR repertoires induced by natural infection, we also analyzed pre F- and post F-binding BCRs isolated from a healthy blood donor with relatively high F-binding memory B cell (MBC) frequencies. Analysis of the vaccine-induced repertoires revealed that preferentially VH4-encoded BCRs were expanded in response to vaccination. Estimation of antigen-driven selection further demonstrated that expanded BCRs accumulated positively selected replacement mutations which substantiated the hypothesis that post F-vaccination induces diversification of VH4-encoded BCRs in germinal centers. Comparison of the vaccine-induced BCR repertoires with clonally related pre and post F-binding BCRs of the healthy blood donor suggested that the vaccine expanded pre/post F cross-reactive MBCs. Interestingly, several vaccine-induced BCRs shared stereotypic VDJ gene junctions with known neutralizing Abs. Once expressed for functional characterization, the selected monoclonal Abs demonstrated the predicted neutralization activities in plaque reduction neutralization assays indicating that the post F-vaccine induced expansion of neutralizing BCRs. 相似文献
3.
4.
5.
6.
《Nutrition reviews》1987,45(10):246-248
Increasing dietary 18:2 n-6/18:3 n-3 causes similar relative changes in fatty acid profiles of phosphatidylethanolamine and phosphatidylcholine from rat neural and erythrocyte membranes. 相似文献
7.
Hisashi Ozasa 《Artificial organs》1994,18(10):768-770
Abstract: Extraction of adsorbed proteins from dialysis membranes that had been used during actual hemodialysis procedures was performed. The condition of extraction with SDS plus 2–mercaptoethanol at 95°C is more efficient than with only PBS or with SDS solution without 2–mercaptoethanol at 37°C. 相似文献
8.
Kurtis W. Andrews David A. Savitz Irva Hertz-Picciotto 《American journal of industrial medicine》1994,26(1):13-32
Although the adverse effect on pregnancy outcomes at high levels of lead exposure in the workplace has been recognized for years, there is uncertainty regarding the impact of exposure at the lower community exposure levels commonly encountered today. This review summarizes the epidemiologic literature and discusses pertinent methodologic issues and possible sources of interstudy variation. The authors conclude that prenatal lead exposure is unlikely to increase the risk of premature membrane rupture but does appear to increase the risk of preterm delivery. Whether prenatal lead exposure decreases gestational age in terms of infants is unclear. Prenatal lead exposure also appears to be associated with reduced birth weight, but results vary in relation to study design and degree of control for confounding. Adjustment for gestational age, a possible confounder of the birth weight-lead exposure association, did not yield clearer results. 相似文献
9.
目的 探讨早产胎膜早破 (pretermprematureruptureofmembranes ,PPROM)的妊娠结局。方法 对 6 5例PPROM进行回顾性分析。结果 6 5例PPROM中以流产引产史、感染及胎位不正多见。孕 2 8~ 34+ 6w 与孕35~ 36 + 6wPPROM比较 ,前者剖官产率明显低于后者 (P <0 .0 1) ,而新生儿发病率明显高于后者 (P <0 .0 1)。结论 对孕 2 8~ 34+ 6w 的PPROM宜采用期待疗法 ,以减少新生儿的并发症 ,降低新生儿的发病率及死亡率 相似文献
10.
Comparison of class and subclass antibody response to live and UV-inactivated RSV administered intranasally in mice. 总被引:2,自引:0,他引:2
To determine the effect of viral dose and replication on the subclass antibody response to RSV, mice were immunized intranasally with different doses of live RSV (10(4)-10(6) pfu) and compared to mice given an immunizing regimen of UV-inactivated RSV. Mice given the 10(6) pfu dose of live RSV and mice given the 40 micrograms dose of UV-inactivated RSV had comparable class specific antibody responses to whole RSV in serum and respiratory secretions. Serum from these two groups of mice were then compared for IgG subclass response to whole RSV. A predominance of IgG2a subclass antibody was found for both immunizing regimens, and no significant differences in subclass proportions were noted between regimens. These two regimens were then compared for serum total IgG response to RSV surface glycoproteins F and G. The serum IgG response to these glycoproteins was lower after immunization with UV-inactivated RSV than after live-RSV immunization (F: P = 0.03; G: P less than 0.05), even though the serum IgG response of the two groups to whole RSV was comparable. The IgG subclass response to surface glycoproteins was evaluated for live RSV immunization. The proportions of subclass antibody responses to glycoprotein F were comparable to the subclass response proportions to whole RSV and were not characteristic of a T-dependent response pattern. The subclass profile for glycoprotein G was not comparable to that of whole RSV but was suggestive of a T-independent response pattern. 相似文献